Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model
<p>The ability of external beam radiation (EBRT) to modulate the tumour immune microenvironment is becoming increasingly well understood, leading to the development of combinatorial EBRT and immunotherapeutic combinations to improve patient responses. Despite this, there is very limited unders...
المؤلف الرئيسي: | Anderson, R |
---|---|
مؤلفون آخرون: | Vallis, K |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2021
|
الموضوعات: |
مواد مشابهة
-
Recent Progress of Functionalized PSMA in Radionuclide Targeted Therapy for Prostate Cancer
حسب: REN Ya'nan, وآخرون
منشور في: (2020-12-01) -
Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
حسب: Solmaz Mojarad-Jabali, وآخرون
منشور في: (2025-01-01) -
Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
حسب: P. August Schubiger, وآخرون
منشور في: (2004-10-01) -
Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
حسب: Paweł Szponar, وآخرون
منشور في: (2023-11-01) -
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
حسب: Alessio Rizzo, وآخرون
منشور في: (2022-11-01)